Courtagen Life Sciences, Inc. Announced Today The Launch Of Two New Next Generation DNA Sequencing Tests For Neurodevelopmental Disorders, Developmental Delay, Intellectual Disability, And Autism Spectrum Disorders
WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., an innovative molecular information company, announced today the release of the devSEEK⢠Sequence Analysis for Neurodevelopmental Disorders Panel and the devACT⢠Clinical Management Panel.
Help employers find you! Check out all the jobs and post your resume.